Hematopoietic Cell Transplantation and Cellular Therapy
147 Medicare Part D prescribers, $203.0M in drug costs.
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
147
Prescribers
$203.0M
Drug Cost
70,761
Claims
$1.4M
Cost/Provider
62
Opioid Prescribers
7.2%
Avg Opioid Rate
29.1%
Avg Brand %
1
Flagged
🔎 Data Overview
Average brand-name prescribing rate of 29.1% is notably high. While some specialties require brand-name medications without generic alternatives, higher brand rates increase costs to Medicare and patients.
Average cost per provider of $1,380,913 is exceptionally high, reflecting this specialty's use of expensive medications. High per-provider costs in specialties like oncology or rheumatology often reflect legitimate clinical needs.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top States for Hematopoietic Cell Transplantation and Cellular Therapy
| # | State | Providers |
|---|---|---|
| 1 | Pennsylvania | 1 |
Flagged Hematopoietic Cell Transplantation and Cellular Therapy Providers
| Provider | Drug Cost | Risk |
|---|---|---|
| Marcin Chwistek | $448K | 41 |
Top Hematopoietic Cell Transplantation and Cellular Therapy Prescribers
| Provider | Claims | Drug Cost |
|---|---|---|
| Marcin Chwistek | N/A | N/A |